These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38987722)

  • 21. Qishen granule alleviates doxorubicin-induced cardiotoxicity by suppressing ferroptosis via nuclear erythroid factor 2-related factor 2 (Nrf2) pathway.
    Xue S; Chen H; Zhang J; Tian R; Xie C; Sun Q; Wang H; Shi T; Guo D; Wang Y; Wang Q
    J Ethnopharmacol; 2024 Dec; 335():118604. PubMed ID: 39047881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account.
    Vitale R; Marzocco S; Popolo A
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
    Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
    Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling.
    Verheijen M; Schrooders Y; Gmuender H; Nudischer R; Clayton O; Hynes J; Niederer S; Cordes H; Kuepfer L; Kleinjans J; Caiment F
    Toxicol Lett; 2018 Sep; 294():184-192. PubMed ID: 29803840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity.
    Pondugula SR; Harshan A; Ramesh S; Govindarajulu M; Almaghrabi M; Majrashi M; Abbott KL; Nadar R; Alturki M; Salamat JM; Smith F; Majeed M; Nagabhushanam K; Moore T; Ren J; Dhanasekaran M
    Cardiovasc Toxicol; 2022 Jan; 22(1):67-77. PubMed ID: 34623620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
    Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M
    J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Changes Associated With Anthracycline-Induced Cardiotoxicity.
    Tantawy M; Pamittan FG; Singh S; Gong Y
    Clin Transl Sci; 2021 Jan; 14(1):36-46. PubMed ID: 32770710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccarin Ameliorates Doxorubicin-Induced Cardiotoxicity via Inhibition of p38 MAPK Mediated Mitochondrial Dysfunction.
    Shi X; Cao Y; Wang H; Zhao Q; Yan C; Li S; Jing L
    J Cardiovasc Transl Res; 2024 Oct; 17(5):1155-1171. PubMed ID: 38886316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy.
    Leger KJ; Leonard D; Nielson D; de Lemos JA; Mammen PP; Winick NJ
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28377429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
    Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
    Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
    He L; Liu F; Li J
    Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
    Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
    Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005006. PubMed ID: 17054231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
    Koleini N; Kardami E
    Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
    Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
    Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.
    Kolur V; Vastrad B; Vastrad C; Kotturshetti S; Tengli A
    BMC Cardiovasc Disord; 2021 Jul; 21(1):329. PubMed ID: 34218797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.